Direct Oral Anticoagulants Is Fastest Growing Segment Fueling The Growth Of Anticoagulant Market

https://www.coherentmarketinsights.com/market-insight/anticoagulant-market-5486
Anticoagulant Market



Market Overview:

Anticoagulants, also known as blood thinners, help prevent blood clots from forming or getting bigger. They are used to treat and prevent conditions like blood clots (deep vein thrombosis, pulmonary embolism), irregular heartbeat (atrial fibrillation), heart attack, stroke and many others. Anticoagulants have advantages over other treatments as they are highly effective, usually do not require frequent monitoring and have minimal side effects.

Market key trends:
One of the key trends in the anticoagulant market is the increasing preference for direct oral anticoagulants (DOACs) over conventional anticoagulants such as warfarin. DOACs have emerged as substitute for warfarin owing to better safety profile, predictable pharmacological behavior with less drug and food interactions, rapid onset of action, and lack of need for monitoring. This has led to their increased adoption in medical practices around the world. Furthermore, patents expiration of blockbuster conventional anticoagulant drugs and robust pipeline of novel oral anticoagulants are some of the major factors expected to drive the growth of global anticoagulant market over the forecast period.

The global Anticoagulant Market Size is estimated to be valued at US$ 36,830.47 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global anticoagulant market is segmented on the basis of drug class, route of administration, application, distribution channel, and geography. By drug class, the market is segmented into NOACs, Heparin & LMWH, VKAs, and others. The NOACs segment dominates the market due to its easy administration, less monitoring requirements, and fewer dietary restrictions compared to VKAs.

Key Takeaways
The global anticoagulant market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing burden of cardiovascular diseases.

Regional analysis
North America dominates the anticoagulant market and is expected to continue its dominance over the forecast period. This is attributed to the growing demand for NOACs drugs and well-established healthcare infrastructure in the region. Asia Pacific exhibits the fastest growth due to increasing healthcare expenditure and rising geriatric population.

Key players
Key players operating in the anticoagulant market are Pfizer Inc., Sanofi SA, Dr. Reddyâ€TMs Laboratories, Aspen Holdings, Abbott Laboratories, Leo Pharma AS, Alexion Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Bristol-Myers Squibb Company, Daiichi Sankyo Company, and Boehringer Ingelheim Pharmaceuticals Inc., among others. Pfizer Inc. dominates the anticoagulant drug market owing to its flagship NOAC drug—Eliquis. Read More: https://www.dailyprbulletin.com/the-growth-of-anticoagulant-market-size-and-share-analysis/

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more